Rob Kimmerling

Rob Kimmerling is the Chief Technology Officer and a co-founder of Travera. He received his B.E. in Biomedical Engineering from Stony Brook University, where he first started working on microfluidic device development for single-cell analysis applications.

Rob continued in this field at MIT where he earned his Ph.D. in Biological Engineering. His graduate work focused on developing novel microfluidic platforms for collecting linked measurements of single-cell biophysical and transcriptional properties.

After graduating, he continued developing these projects as a Research Scientist at the Koch Institute for Integrative Cancer Research at MIT, where he led a team utilizing these approaches to characterize transcriptional signatures associated with single-cell drug susceptibility in various malignancies.